lijekovi.ppt

7/25/2019 lijekovi.ppt

1/41

NAA AST I NAA SLAVA


2/41

U RAT PROTIV BAKTERIJA I RODBINE

-ANTIBIOTICI

-ANTIBAKTERIJSKASREDSTVA

UPORABA PLIJESNI NA RANE PRIJE 4.500 GODINA U KINI.


3/41

PENICILINI

CEFALOSPORINI

TREI OVJEK.


4/41

AMPICILINR20/22-3/3! "#$%$&' ()' *+ +,#% '1+$( &(,(+%' )'+6PENICILIN G&% (78*$(8( *%CEFALEKSIN&% (78*$(8( *%

K+& '9%:(%1*)%

%();%.O$'8(&(


5/41

TETRACIKLINI I MAKROLIDI

TETRACIKLIN I OTCR20/22-3! "#$%$&' ()'*% +,#% '1+$(&(,(+% )'+.

A=ITRO>ICIN ? &%:((78*$(8(&(.

R%: ,'7(&(*:+(;':.


6/41

A>INOGLIKO=IDI

A>IKACIN R3/3@/3! "&(,(-+% ' ,#&% +$'8% )'+6TOBRA>ICIN *$' )(' 1'%

GENTA>ICIN R42/43 :'%7(78($ %'*%$8'*$+,*(&%: + ,',+ *)'':6

NEFROTOKSINOSTOTOTOKSINOST

PREPORUUJE SE PRAANJE KONCENTRACIJA U KRVI.


7/41

ANTIBAKTERIJSKA SREDSTVA

Jednom davno u P!v!.

B'& *+'&(:, $:%$': R3/3!"&(,(+% ' )'+6

P+&' &%*'(7+:( ')'&%'$')*&'* (;%$

:%$(9'$(.

OSTAO JE SINERSUL


8/41

NAJVANIJE JE SAUVATI IVCE

(&$*'$;(&$,%%*89%&7',(7%&*) $(&)87($'*%,($8

*'*$:+(&*(&%*$%$;(&(1%$;(&$)'&8+78

(&$()&*'&;,+1 "&. *%,*$8( 7( *(8(&%6.

APSOLUTNO NAJE"A OTROVANJA


9/41

ANTIPSIOTICI

-%&'$(7&-$')*(&$%&-9+$'%&'&.

K'':(7& R25/2-3/3!"'$'8&' ()' *% '1+$( +,#% &(,(+% '

)'+6


10/41

=(9(&%&'7( 8'7(%

ALOPERIDOL RR25-3/3! "'$'8&' ()' *%'1+$( &(,(+% ' )'+6

U7 ('%,' 8%7(&( '(8( %)*$((:,(&'1 *&,':(.


11/41

ANKSIOLOTICI I ANTIDEPRESIVI

T%*)'9( B%78'&'*$


12/41

BEN=ODIA=EPINI. P%$%&' (&)*'$; *%,($8 ( $()'% :'1+ 9$

A&$)'&8+78 "&. K'&(7%(:6 *% )'*$% )',&%*(&;%.2. $%$&% $8( * '7&()': R22 "#$%$&' ()' *% '1+$(6( LD50 : % ')' 1/)1.3. N(%#H( '$'8(&( $' +1(8&': + )':9&(; *,+1: '(*&: %)'8:(.4. I7(7$' :( 9' %$(& 7(8#%$()( )', '$'8(&(*(:' 9%&7',(7%&:(.5. P'*$' (&$,'$ +:(7%& "(&$(1'&*$6 ()' +&)'8$

()' *)+.. P()$) *8()( )+H( ,(&(* + *8'' ('$%; :(&%) ', 9%&7',(7%&(. G'%:( '$'#&(.@. D',($& '9%: % '8*&'*$.


13/41

TRICIKLIKI I DRUGI ANTIDEPRESIVI

.N%) ', & *+ '$'8& * '7&()': R25 "'$'8&' ()'

*% '1+$(6 R4!/22 "$%$&' '(*&'*$ ', $%#)'1'#$%H%&( 7,(8( ,+%: 7(1(&+ 1+$(&%:6.N%'$')*& &%+'$')*& )(,'$')*&.2. D+1' 8%:% 7( '*$7(&% ,&(:)% (8&'$%% )',

)'&&% $%(% ",8( $%,&( 8#%6 ( *% +%*$(' $(%9'( %#%&( "&. +,(&% ,'7% * 9%7 %$',&*:+(;(63. V%) 8'+:%& (*',%% $%() 79' '$:(&%$%&)% 78(&$%%*&% %:&(;%.4. P(H%&% )'&;%&$(;( + )8 + +$& &)(, &%=(8%' 7((8' *% )'*$ 7( ';%&+ $%&%

'$'8(&(.


14/41

FLUOKSETIN

.>(&% '$'8(& ', $;)) (&$,%%*8( *

O7&()': R22 "#$%$&' ()' *% '1+$(6.2. P+&' &+*'(8( "&%*(&;( (&'%)*( (,9,( ',&'*&' '$%&;% $,.6.

3. N(1'% *+ *+:&%+ :'1+H% $%($'1%&%+&)% ( 7( *(, &%:(H8*$ ,')(7( + +,.


15/41

B'(& (%)$8& '%:%H(.

LITIJ. A)+$&( '$'8&'*$ :+ % %($8&' &*)( R22 "#$%$&' ()' *%'1+$(

2. K'&&' % &%'$')*(& #$%$&' ,%+% &( +&);+#$$&(% ( :( '7&()+ R40 "'1(&%&( *(7&(&( ')(;&'1%&: +&;:(6.3. V' +&)'8$ )(, *% %,'8$' +7:(-'9%: ;':(&;%.

4. S)'' 40 1',&( ',)()' *% ($% )'&;%&$(;%

5. O98%7&' ($$ +&);+9+9%1( #$$&(%.. L%) 7( ;% 8'$


16/41

ANTIEPILEPTICI

B'%*$ 8%)(&( ( ,(&(* 79'1 $(+:(.


17/41

antiepileptik CAS broj znakovi opasnosti oznakeupozorenja

karbamazepin 298-46-4 Xn R22

fenitoin 5-4!-" Xn

# $ar%& kat& 2

R48'22-(6

R2('24'25-45

valproi)nakiselina

99-66-! # R22-('(8-6!

fenobarbiton 5"-"6-6 # R25

etosuksimi* -6-8 Xn R22

primi*on !25-((- Xn R22

TOKSIKOLOKE =NAAJKE NEKI ANTIEPILEPTIKA


18/41

KARBA>A=EPIN

T%#)% )'&% &+*'(8%.

. A)+$&( '$'8(&( %$)( "&. '$%&7(62. B'&% &+*'(8% ",%%*( SS )'&% &+*'(8%63. T%() $%(*) '9%: 79'1 '$%9% )':9&(;%* ,+1: (&$%%$;:( *$(& ':%&( + 97&9'$(&*':(;%.

4. O98%7&' (H%&%)'&;%&$(;( + )8'*%9&' )', $%(*)'9%:(.5. %*$% &$%();%.


19/41

G!n#!va $od v!%o$!& do'a (en!)o!na.

FENITOIN. L%) 7 3!. * ,'9': +&)'8$'#H+ ( 9'&:'9%::( "'*%9&' )', )'&&% +'(9%6.

2. %*$' *% )':9&( * ,+1: (&$%%$;:( (I&$%();% *+ 9'&% "&. &,+);( %&7:(6

3. O98%7&' % (H%&%

)'&;%&$(;( + )8 % 9%7$'1( &%:( +&)'8$%$%(%.4. O,&'* 7:%+ (7&( +)8 +&)( &% +8%)

(*(&.

FENOBARBITON


20/41

FENOBARBITON. P(*$( %) 7 2. )'#$%& 7( (7$% *8% )',(7& 9'%*$ "S%H($% *% >(& >'&'%


21/41

F%$(& 8('& *&,':.

VALPROINA KISELINA

.A)+$&( '$'8(&( &*+ '9%:.

2.B'&% *+ &$%();% "'$*)+% ,+1% %)'8%* (9+:&( :'% &9($*&$%7+ :)'*':(& ')*,(7(.

3. N(8%H '9%: % + *+:&&( $%($'1%&'*$.O98%7&' % (H%&% &%7&)'&;%&$(;( + )8.

4. L()' *% +)(&( 7 )8'*(&': ()(&': ,+%7':.


22/41

ANTIPARKINSONICI

JAA OD ALIJA.

.U 8($*)' :( ')' 20.000 9'%*&)(2.T%(( % 8' *'%&( %*$' &%+&)'8$(

3.>'% *% ,%'8($ $%) &( *:$':% 9'%*$ (&+*'(8% &$%();% *+ 7(7$' %*$%.

4.P()$) &%:( ()+$&

'$'8(&(.5. S$(&' *% '(8++ &'8%)'8 ( 8,&'1 &(%$)(7((8' &%:(.

. N(8%H '9%: % #$'*+ 9'%*&; *8%*& 9'%*$ :%&$(&' + 78*&': *$(&+


23/41

lijek CAS broj znakopasnosti

oznakaupozorenja

levo*opa 59-92- Xn R22-(6'('(8

tri+eksfeni*il !44-!!-6 Xn R22

*ifenil+i*ramin

!4-24-" Xn R22

benztropin 86-!(-5 Xn R2"'2!'22-4"

amanta*in 665-66- Xn R22

NAJEI ANTIPARKINSONICI

ANALGETICI I ANTIPIRETICI


24/41

F','8( 9'.

ANALGETICI I ANTIPIRETICI

.B' % *(:( ' *%9 %*$( &% *(*8: (*&('(8( ( 9' (&(1%$)( % 7+7%$&' 8%). T(9%$%*% :'1+ &(H ()$) + *8()': ,%+.

2. N $%($+&: ',(;:(

*% &% :'% *(*8:8%'8($ #$' *% $%#$%$& +&()( % :

% () *$($+* (7$ &(

(7&: $#$:(.


25/41

lijek CAS broj znakopasnosti

oznakeupozorenja

a%etilsali%ilnakiselina

5"-8-2 Xn R22-(6'('(8

para%etamol !"(-9"-2 Xn R22-('(8

*iklofenak !5("-9-6 # R25-(6'(8-

6(

TOKSIKOLOKE =NAAJKE NEKI OD ANALGETIKA

T+ &((8&' &%:( '& :'H& '+$ ,%8($( :'(. O&:( &( ,+1': :%*$+.


26/41

ACETILSALICILNA KISELINA

. N(8',&' *+ 7( &%7&% %)*$()$% 7&( K&%7 '# %4.000 1',&( ( + E+' '*$' 7 . *$'%H(.2. N%:(:' +&' ()+$& '$'8(&( ( )'*$ *% 7( (7&%*8% "O%$ '*$(% :',%(& %) 7( 7(#$$+ )8& (6.3. B' &$%();( &+*'(8( % 7(7$' 8%)

4. U A:%; 9%% 7(7$'+&' '$'8(&( ( + &(* %%$)' +7') ()+$&'1 '$'8(&(.5. A)+$&( '$'8(&( *% ()'

%#(8(+ ()(&': '*(&':,+%7':.

PARACETA>OL


27/41

PARACETA>OL. I7(7$' )'&$'8%7(& %). A:%)(&; 1( *% 9'% #+ *8()()8% *$(#&% $8( ( : &%:(:' '$'8(&(.

>',( 79'1 &%&;% ,( )', &(*&% ,'(7 + '8()' 8%): ()(-&:( &% :'% 1( *% )+$ +

*8()': ,+H(&+.2. G(8& '9%: % %($'$')*-&'*$ )()' )', ()+$& '$'8(&(T()' )', )'&&% :%&%.

3. N%:( (&$,'$( &$ ()' ,'9%$%&)% 78(&$%%*&% %:&(;%.4. D'(7 + *$'$&(:( )':9&(&%(($(.

VOLTAREN


28/41

VOLTAREN. T(& %,*$(8&) 9'& #')' )'#$%&&%*$%',& (&$%+:($)(. S8 :'1+H (8;.

2. B'&% &$%();% * ,+1: %)'8:( $8(:("&. ()''6 ,+1: '+$ (&%.3. OH%&$' $%#) (*';*) '9%: )(' )*%&(.

4.B'&% &+*'(8%*&' )(' )',(;%$*(;&% )*%&%.5. S+:&8 79'1

:'1+H% $%($'1%&'*$.

LIJEKOVI =A BOLESTI SRCA I KRVNI ILA


29/41

J( '*'9&' 8#% 8': (&%$&+.

LIJEKOVI =A BOLESTI SRCA I KRVNI ILA

.=&(:' ,( 8($ &(%#H% +:+ ', $ 9'%*$.2.K(+ ,( $%9( #$' :(&% %*$ ( #$' 8#% *% )%$($

( $' *% ,(&(* 8#% &)': &% ,(. K')' *% 8 $'#$%( )')' *%,$%ICI


33/41

K&,&*)( $':9';$'%&(

ANTIARIT>ICI. I & :( +&' )(' &. ')(&(:, )&,& 8%((:(:',('& ,7'(:, $,.

2. R(7$ %:( '$'8&'*$ ,+1'$(&: +&;:( &((8&'(:()')&%$;.3. T%#)' % 7(9($ (8 (&$($:) ( &( $#$+ ,'(7% '#+8%) 8%H&( ', & 9%7 '97( &( *$('*$ '9%:%.

4. T(& :% '9%:(8%% *% +7 ')(&(:,"++* )% *&,':6 ( *% '#+8%) )'*$.5. P%'++% *% :%$)'&;%&$(;% + )8 &,8,+(7(; $%(%.. O$'8(&( + (8+ $%(*)(( (&$,'$( &%:(.

ANTIIPERTEN=IVI


34/41

ANTIIPERTEN=IVI. N(%#H %)'8 7 *)+&% ( (7$ ' :%(&7:+D%'8(&( "&. 9%$( 9')($' ,+%$; $,. L%)'8 7( ;% 8'$.

2. A)+$&( '$'8(&( ()$) 9%7&((&( ( %*$ $%(*)P'9%: 79'1 9'& (7'1(.

3. B'&% )':)(;% '+$&. %,%:(-$'$(& '%:%H(

(:()')&%$)%.4. T%() '9%: *+(,&% *%&)': + $%( "&%*+(,&(6.5. V%) &(' (:(;%+$*)%&,+*$% + 7(, %)'8( 7(&%'*+#&%.. N%:( (&$,'$( &$ *+ '$%9&.

PLUA NAA


35/41

PLUA NAA

A*$:($& &((, + B(&1')+.

. S(:' ', (*$:% 9'+% ')' 4 +(&*$8( ( ,( ' '*$(:+H&: 9'%*$:( &% 1'8':'.2. L%)'8( % &((8&' :&'1' + (7&: '9;:( * (7&:U&;:( ( ',+% % #')'.3. G(8& '9%: *+(,&( 9'%*&)( * %&)': ( '$'8(&(

*+ 7(7$' %$)(.4. K', &%) % 7(7$'8(&' ($$ $%(+:%%&%: )'&;%&$(;( +)8 ( %$%&' 79'1'*$7(&( +&)( ( &% 79'1

&+*'(8(.5. B'& &$% :'1+ :($+$%;(( &( (:()')&%$)+ +&)'8$'*$ "&. %,%:6


36/41

lijek CAS broj znakoviopasnosti

oznakeupozorenja

*inatrijevkromo,likat

!5826-(-6 Xn R22

+i*rokortizon 5"-2(- Xn R2"'22-((

salbutamol !8559-94-9 Xn R22

teofilin 58-55-9 Xn

1#

R22-(6

1R2"'2!-25

terbutalin 2("(!-25-6 Xn R22

TOKSIKOLOKE =NAAJKE NEKI ODANTIAST>ATIKA


37/41

V'$% ( * $%&':%%&%: )'&;%&$(;( +)8.. A (,'8( ' &%:+ % &(%$%

KORTIKOSTEROIDI


38/41

N+*'(8( )'$)'*$%',(.

KORTIKOSTEROIDI

. D%++ '$+(%1*) '$++(&' ( *+ )', $%(%(*$:% 7(7$' 8(& ':'H& () 1(8& %)'8.

2. P:%&( &( (7$% &(&% ', &$(8%&*)% ,' &((;':( +8%) +7 '%7 79'1 :'1+H &+*'(8(.

3. S:($( *% '$%9&P'7'&' ($$ *8%

9'%*&)% +(8' 79'1&+*'(8( )'% *%'8(H% %*$(&)':$%(%.

OS S


39/41

S(:' :'7() &% %*(++.

I>UNOSUPRESIVI

. =( *(, ;)'*'& $()':+*+ ( &(8',&' $(,':, :(

8%)% #(&*% + 9+,+H&'*$.2. P'*$'%H :+&'*+%*8 8' '$'8& :(+ +*)+ $%(*)'P',+%. O98%7&' (H%&% )'&;%&;$(;(.

3. T%() '9%: +$%;(( %)'8(

&( 8(*$$+ (:()')&%$)+ ? '9%:&+*'(8( #$%$& +&()(.4. I7(7$' 8(&' ,($ )'&;%&$(;%+ ',++ 7&(, :&:(&,%'$8'& )'&;%&$(;( 79'1:'1+H&'*$ ',9(;8(&( '1(&(5. L%)'8 7( ;% 8'$.

CITOSTATICI


40/41

R() &% 9( & %:( ,'9.

CITOSTATICI. I:( ,'*$( "&. :%$'$%)*($ ;*($&+: $,..2. K+& '9%: % + &+*'(8(:( "', 9%7(7%& '+$

'(,(&( )'*% %)' +(*& :+&&( ,' $%#) '#$%H%&('1(&( '+$ %$%.3. N(& :%&% *+ 7(7$' 9'& +1(8&': * &(:%':D( *% '1', ;& $+:' ( &':(&% *$(&;% '*$(8% &( :+.

4. I&,8,+(7(;(

$%(% '9(8( *%9(%: 25 1',&( )',&(* + *8%$+. P'*$'%'*%9& %: ,'7(&(

&. 7( :%$'$%)*($.5. U (8+ *% )'*$%)':9&(;% (7&$%$:(&( "&. 7(%&%6

DOSTA O LIJEKOVI>A


41/41

DOSTA O LIJEKOVI>A

. A () $%9( '&'8$ ,( *:' : 8($ ,( 7(7$' :&'1'&( '78',& (*(&+ %)'8( 7( *8'% $+% '$%9%.

2. I:( *:' '1&(& '*$+() 7( '78',&+ C 8$(:&(:%+ 8:( + *8%$+.3. P'78', *:' (;%$*(;&+ )*%&+ %:( 8(*$$':'78',&': '*$+)+.

4. >' ($% *+ % 301',&( '1(&7( 8(*$$'*$+() 7( '78',&+%&;(:&(.

5. D(&(* ')'& 7&(&*$8%&)% &((8' ,+1 '*$+() 7(*&$%7+ ((+&(.. J% $' '$;(&' 7( :(,%

Documents

lijekovi.ppt